1,469 research outputs found
Distribution of Human Papillomavirus Types in Different Histological Subtypes of Cervical Adenocarcinoma
Little information is available regarding distribution of HPV types in different histological subtypes of adenocarcinoma
(AC). Thus, in this study we examined the frequency of high-risk (hr) HPV types in AC, adenocarcinoma in situ
(AIS) and adenosquamous carcinoma (ADSQ). A total of 102 cases of primary cervical adenocarcinoma (26 AIS and 76
invasive AC) obtained from pathology files from 1995ā2006 were histologically subtyped. Our results demonstrated that
endocervical type occupied the major subtype of AC (22/66) followed by ADSQ (17/66) where as in the group of AIS
endocervical type (12/23) was followed by intestinal type of AIS (7/23). Successful DNA extraction was obtained in 89
samples; 81 out of 89 (91.0%) tested positive for HPV DNA. The prevalence of HPV DNA in AIS, AC and ADSQ was
91.3% (21/23), 90.9% (60/66) and 94.1% (16/17), respectively. We found HPV 18 type to be the most predominant type in
AIS (11/21) and AC (17/60) followed by HPV of undeternmined type in AIS (3/21) and HPV 16 in AC (9/60) as the sole viral
type. HPV 18 was most frequently detected type in all histological subtypes of AIS and AC. We have detected HPV
DNA in all 5 samples of clear cell carcinoma (CCC), although other studies have reported a highly variable prevalence of
HPV DNA in CCC. The most prevalent HPV type in ADSQ was HPV-16 followed by HPV 33 as single type. The observed
overall predominance of HPV 18 in AIS (
2= 6.109, pĀ£ 0.025) and AC (
2 = 8.927, pĀ£0.01) as well as of HPV 16 in ADSQ
(
2 = 10.164, p Ā£ 0.01) was statistically significant. Our data revealed statistically significant predominance of single
hrHPV infections in AIS (16/21;
2 = 11.523, p Ā£ 0.001) and AC (37/60;
2 = 6.533, p Ā£ 0.025) whereas multiple hrHPV
infections were more abundant in AC comparing to AIS (23/81and 5/81, respectively;
2 = 13.989, p Ā£ 0.001)
Temeljna naÄela kirurÅ”kog lijeÄenja zloÄudnih ginekoloÅ”kih novotvorina
In the treatment of gynecologic malignancies surgery represents a cornerstone of gynecologic oncology. Surgery is important to establish the definitive diagnosis, to define the extent of disease and to eliminate the tumor according to the type and localization. The most frequent tumors among gynecologic malignancies are cervical, endometrial and ovarian cancer. Actual surgical approach in early cervical cancer with microscopic extension includes conservative techniques, in the first place the use of conisation. In the same group of patients but with fulfilled reproductive activities, hysterectomy is recommended. Radical surgery could be applied in invasive cervical cancer staged IB1 to IIA. Surgical treatment in the advanced stage of cervical cancer could be exerted exclusively in controlled trials as a part of multimodal treatment.
Endometrial cancer still remains incompletely defined in the extension of surgical procedures. Namely, lymphadenectomy in patients with endometrial cancer according to the low rate of lymphatic dissemination is not completely accepted in hospital daily practice. Furthermore, the increasing use of minimal invasive surgery transforms our way of thinking, especially in the case of endometrial cancer. Ovarian cancer still remains an unresolved diagnostic problem with negative implication in the treatment efficacy. About two thirds of patients are in advanced stage at the time of their first surgery, primarily for the lack of a high effective screening test as well as unknown pathophysiology in early ovarian cancer development. In early ovarian cancer comprehensive staging should be done, while in patients with advanced disease standard approach should include maximal effort in surgical cytoreduction.KirurÅ”ki tretman malignih novotvorina ženskog spolnog sustava predstavlja poÄetak i osnovu svakog onkoloÅ”kog lijeÄenja. KirurÅ”ki je zahvat, naime, od temeljne važnosti pri postavljanju konaÄne dijagnoze, odreÄivanju stadija bolesti, kao i za uklanjanje tumorske mase tijekom prvog operacijskog zahvata sukladno lokalizaciji i vrsti malignoma. NajÄeÅ”Äu pojavnost malignoma ženskih spolnih organa nalazimo na cerviksu, endometriju i ovariju. Suvremeni kirurÅ”ki pristup lijeÄenju ranog stadija - mikroskoposkog raka vrata maternice ukljuÄuje konzervativne zahvate u smislu konizacije. U sluÄajevima gdje je reprodukcija zavrÅ”ena može se posegnuti za histerektomijom. Radikalna kirurgija predstavlja metodu izbora u kliniÄki invazivnom obliku bolesti (stadij IB1 do IIA). KirurÅ”ko lijeÄenje viÅ”ih stadija može se rabiti u kontroliranim studijama u sklopu multimodalnog lijeÄenja. Rak endometrija i dalje ostaje u odreÄenom smislu nedovoljno definiran u smislu opsežnosti samoga kirurÅ”kog zahvata. Naime, limfadenektomija kod bolesnica s rakom endometrija s obzirom na relativno nisku stopu limfogenog rasapa i dalje predstavlja kamen spoticanja u kliniÄkoj praksi. S druge strane, sve opsežnije uvoÄenje endoskopske kirurgije otvorilo je nepovratni put ka prihvaÄanju operativnih zahvata s minimalno invazivnim tehnikama. Rak jajnika joÅ” uvijek predstavlja veliki dijagnostiÄki i terapijski problem. Kako ne postoje Å”iroko primijenjeni uÄinkoviti testovi probira, bolest se u dvije treÄine bolesnica otkriva tek u uznapredovaloj fazi s posljediÄnom visokom stopom smrtnosti koja premaÅ”uje zbroj smrtnosti svih preostalih ginekoloÅ”kih malignoma. U bolesnica s naizgled ranim stadijem bolesti potrebno je uÄiniti sveobuhvatni kirurÅ”ki zahvat radi odreÄivanja toÄnog stadija bolesti, dok u bolesnica s uznapredovalom boleÅ”Äu standardni pristup ukljuÄuje optimalnu kirurÅ”ku citoredukciju
Temeljna naÄela kirurÅ”kog lijeÄenja zloÄudnih ginekoloÅ”kih novotvorina
In the treatment of gynecologic malignancies surgery represents a cornerstone of gynecologic oncology. Surgery is important to establish the definitive diagnosis, to define the extent of disease and to eliminate the tumor according to the type and localization. The most frequent tumors among gynecologic malignancies are cervical, endometrial and ovarian cancer. Actual surgical approach in early cervical cancer with microscopic extension includes conservative techniques, in the first place the use of conisation. In the same group of patients but with fulfilled reproductive activities, hysterectomy is recommended. Radical surgery could be applied in invasive cervical cancer staged IB1 to IIA. Surgical treatment in the advanced stage of cervical cancer could be exerted exclusively in controlled trials as a part of multimodal treatment.
Endometrial cancer still remains incompletely defined in the extension of surgical procedures. Namely, lymphadenectomy in patients with endometrial cancer according to the low rate of lymphatic dissemination is not completely accepted in hospital daily practice. Furthermore, the increasing use of minimal invasive surgery transforms our way of thinking, especially in the case of endometrial cancer. Ovarian cancer still remains an unresolved diagnostic problem with negative implication in the treatment efficacy. About two thirds of patients are in advanced stage at the time of their first surgery, primarily for the lack of a high effective screening test as well as unknown pathophysiology in early ovarian cancer development. In early ovarian cancer comprehensive staging should be done, while in patients with advanced disease standard approach should include maximal effort in surgical cytoreduction.KirurÅ”ki tretman malignih novotvorina ženskog spolnog sustava predstavlja poÄetak i osnovu svakog onkoloÅ”kog lijeÄenja. KirurÅ”ki je zahvat, naime, od temeljne važnosti pri postavljanju konaÄne dijagnoze, odreÄivanju stadija bolesti, kao i za uklanjanje tumorske mase tijekom prvog operacijskog zahvata sukladno lokalizaciji i vrsti malignoma. NajÄeÅ”Äu pojavnost malignoma ženskih spolnih organa nalazimo na cerviksu, endometriju i ovariju. Suvremeni kirurÅ”ki pristup lijeÄenju ranog stadija - mikroskoposkog raka vrata maternice ukljuÄuje konzervativne zahvate u smislu konizacije. U sluÄajevima gdje je reprodukcija zavrÅ”ena može se posegnuti za histerektomijom. Radikalna kirurgija predstavlja metodu izbora u kliniÄki invazivnom obliku bolesti (stadij IB1 do IIA). KirurÅ”ko lijeÄenje viÅ”ih stadija može se rabiti u kontroliranim studijama u sklopu multimodalnog lijeÄenja. Rak endometrija i dalje ostaje u odreÄenom smislu nedovoljno definiran u smislu opsežnosti samoga kirurÅ”kog zahvata. Naime, limfadenektomija kod bolesnica s rakom endometrija s obzirom na relativno nisku stopu limfogenog rasapa i dalje predstavlja kamen spoticanja u kliniÄkoj praksi. S druge strane, sve opsežnije uvoÄenje endoskopske kirurgije otvorilo je nepovratni put ka prihvaÄanju operativnih zahvata s minimalno invazivnim tehnikama. Rak jajnika joÅ” uvijek predstavlja veliki dijagnostiÄki i terapijski problem. Kako ne postoje Å”iroko primijenjeni uÄinkoviti testovi probira, bolest se u dvije treÄine bolesnica otkriva tek u uznapredovaloj fazi s posljediÄnom visokom stopom smrtnosti koja premaÅ”uje zbroj smrtnosti svih preostalih ginekoloÅ”kih malignoma. U bolesnica s naizgled ranim stadijem bolesti potrebno je uÄiniti sveobuhvatni kirurÅ”ki zahvat radi odreÄivanja toÄnog stadija bolesti, dok u bolesnica s uznapredovalom boleÅ”Äu standardni pristup ukljuÄuje optimalnu kirurÅ”ku citoredukciju
Treatment of Invasive Cervical Cancer: Rijeka Experience
The aim of this retrospective analysis was to evaluate the survival rate in 661 patients with cervical cancer regarding
two time periods 1990ā1996 and 1997ā2003 and the specific stage related risk factors. The respective five-year survival
was 71.7% and 80.0%. Analyzing the risk factors in the univariate and multivariate regression modalities ultimately
only two parameters, the two time periods and FIGO staging were found to be independent prognostic factors. The observed
total improvement in the survival rate of the second time period is followed by an increase in conservative surgery
in stage T1A1, a reduction in the use of adjuvant radiotherapy among operable stages T1b1, T1b2 and T2A, while the
treatment of locally advanced cervical cancer did not differ significantly
- ā¦